Ineffective Photodynamic Therapy in Retinoblastoma
Author Information
Author(s): L. White, C.J. Gomer, D.R. Doiron, B.C. Szirth
Primary Institution: The Prince of Wales Children's Hospital and Clayton Center for Ocular Oncology
Hypothesis
Can photodynamic therapy (PDT) using haematoporphyrin derivative (HPD) effectively treat retinoblastoma in a xenograft model?
Conclusion
Photodynamic therapy was ineffective in treating retinoblastoma due to the poor vascularization of the tumors.
Supporting Evidence
- HPD-PDT did not influence tumor growth in any treatment group.
- Control tumors progressed to fill the eye in an average of 3.3 weeks.
- Chemotherapy with cyclophosphamide was effective in reducing tumor growth.
Takeaway
The study found that a light treatment for eye cancer didn't work because the tumors didn't have enough blood supply.
Methodology
The study involved injecting retinoblastoma cells into the eyes of nude mice and treating them with various therapies, including HPD-PDT and cyclophosphamide.
Limitations
The model may not fully replicate human conditions, and the small size of the tumors limited the effectiveness of HPD-PDT.
Participant Demographics
Nude mice of both sexes were used in the study.
Want to read the original?
Access the complete publication on the publisher's website